fbpx

Press Release

John Oliver’s “One Size Fits All” Approach For PFAS Is Misguided

Washington, DC –  British showman and comedian John Oliver, known for his punchy and thorough rants on public policy, has set his sights on a new target: man made chemicals, known as PFAS. In his now viral rant, Oliver explains how PFAS chemicals are problematic for human health and wants all of these chemicals to be declared hazardous by law. This is, in fact, what Congress is attempting to do via the PFAS Action Act, which has passed the House and is waiting for a final vote in the Senate.

David Clement, North American Affairs Manager with the DC based Consumer Choice Center urged caution in regards to regulating these man made chemicals: ” While some bans or restrictions might very well be needed and justified, banning an entire category of evolving products won’t serve the consumer. A more appropriate response would be to evaluate these chemicals and substances based on the risk they present and how they are used, rather than lumping them all together and risk enacting bad policy that will have a myriad of consequences.”

“For example, these chemicals are commonly used to create a long list of medical devices and equipment and done so in a way that presents very little risk to human health. To declare all these chemical compounds hazardous, without evaluating the risk associated with each use, puts lifesaving medical technologies in jeopardy and patient safety at risk,” said Clement

“These chemicals are also used in the production process for smartphones, which 270 million Americans currently use. As cell phones and 5G technology continue to grow and require faster speeds at smaller sizes, these compounds are involved in everything from producing semiconductors to helping cool data centers for cloud computing. Forcibly removing these chemicals from the production process, even when they present very little risk to humans, will drastically disrupt supply chains and inflate costs that will hurt low-income people the hardest,” said Clement.

“Rather than a “one size fits all” approach to PFAS, regulators should keep in mind that risk is established by looking at the hazard a substance presents, and the exposure to that hazard. There is a significant difference between the dumping of these chemicals into water ways, which is atrocious and should never happen, and the necessary use of these chemicals in various production processes, which pose little to no risk to consumer health and safety. Failing to see the difference, and lumping all of these modern chemicals into one regulatory basket, will create a laundry list of negative externalities,” said Clement

Parlamento Europeu envia carta em defesa da PI à Câmara e ao Senado

Brasília, BR – Foi protocolada hoje, quinta-feira, 23 de Setembro, uma carta enviada do Parlamento Europeu aos Presidentes da Câmara dos Deputados, Arthur Lira, e do Senado Federal, Rodrigo Pacheco. Na carta, 11 membros do Parlamento Europeu expressam suas preocupações com relação ao futuro da propriedade intelectual no Brasil após a Lei nº 14.200 de 2 de setembro de 2021, que prejudica o ambiente de propriedade intelectual (PI) no Brasil, ser aprovada. A carta questiona como as indústrias europeias, de muitos setores que dependem de proteção de PI, podem investir e comercializar no Brasil. A carta teve apoio do grupo internacional de defesa dos consumidores Consumer Choice Center e da Frente Parlamentar pelo Livre Mercado.

“Temos uma relação comercial muito próxima com o Brasil, e por isso estamos preocupados com o caminho que o Brasil vem seguindo no que diz respeito às leis de propriedade intelectual” disse em nota Gianna Gancia, MEP. “Países com fortes regimes de PI estimulam a inovação e a criatividade e são necessários para o crescimento econômico, a competitividade e a criação de empregos. Infelizmente, a PL nº 12/2021, e a consequente Lei nº 14.200, não ajudam o Brasil a cumprir os objetivos traçados na Estratégia Nacional de Propriedade Intelectual” concluiu Gancia.

“A exigência existente no PL nº 12/2021 que determinava que as empresas compartilhassem os seus segredos comerciais não tem precedentes e é inconsistente com as obrigações de proteção de segredos comerciais do acordo TRIPS. Forçar a transferência de tecnologia negaria aos inovadores a certeza e a previsibilidade necessárias para investir com confiança e acelerar o lançamento de novos produtos no Brasil” disse o Deputado Paulo Ganime, coordenador de Inovação da Frente Parlamentar pelo Livre Mercado. Para ele, “o governo acertou em vetar essa parte do texto, que poderia prejudicar a nossa credibilidade. O mais importante agora é garantirmos que o veto será mantido”, acrescentou.

Para Beatriz Nóbrega, Secretária Executiva da Frente Parlamentar do Livre Mercado, “existem alternativas melhores para criar no Brasil um ambiente que promova a inovação, o investimento estrangeiro direto e o acesso a novos produtos. Queremos ampliar as parcerias comerciais do Brasil no exterior e para isso precisamos honrar nossos acordos internacionais e buscar políticas que protejam a inovação e a criatividade, com o objetivo de deixar claro que no Brasil há estabilidade jurídica.”

Para Fábio Fernandes, Diretor de Comunicação da associação de consumidores Consumer Choice Center (Centro de Escolha do Consumidor), esta mudança na Lei preocupa muito os consumidores e pacientes brasileiros, pois decidirá o futuro da inovação nos campos da tecnologia, agropecuária e medicina.

“Os consumidores estão preocupados com a possibilidade de novos produtos, tecnologias e medicamentos não estarem disponíveis no Brasil por uma insegurança jurídica. A lei de propriedade intelectual no Brasil está de acordo com o padrão internacional porém essa nova lei, somada à recente decisão do STF sobre o Artigo 40 da Lei de PI, pode enfraquecer esse direito pondo em risco o futuro da inovação no Brasil” afirmou Fernandes. 

“Vacinas para o setor de agropecuária, remédios contra o câncer, componentes de informática como microchips para celulares, e até inteligência artificial são alguns exemplos de produtos e inovações que podem atrasar ou até mesmo nunca chegar ao mercado brasileiro” concluiu Fernandes.

Leaked Europe’s Beating Cancer Plan threatens consumer choice

A leak of the upcoming “Europe’s Beating Cancer Plan” signals the European Commission’s determination to create a “Tobacco-Free Generation” by turning a blind eye to science. In particular, according to the leaked proposal (attached below), the Commission fails to acknowledge vaping as an innovative way to reduce harm associated with smoking and as a method to help smokers quit.

The leaked proposal reveals the push to expand taxation to “novel tobacco products,” including vaping; extend the coverage of the smoking bans indoor and outdoor to e-cigarettes, and a broad flavour ban.

“Europe’s Beating Cancer plan is a momentous opportunity to embrace innovative ways of fighting cancer. The stakes are extremely high, and the European Union simply cannot afford to get it wrong. Vaping was invented to help smokers quit by providing them with a safer alternative. As of today, endorsing vaping is the best-known way to balance out an urgent need to reduce cancer rates and the need to protect consumer choice of current and future generations in the EU,” said Luca Bertoletti, Senior European Affairs Manager at the Consumer Choice Center.

“Vaping has gained popularity among European smokers precisely because it reduces harm. The proposed restrictive approach won’t drive down demand. Rather, it will result in a spike in illicit trade which, in turn, will endanger European consumers and increase the budget losses from uncollected taxation.

“If the European Commission proceeds with this version of the plan, it will not only fail to fight cancer, but will also miss out on a chance to put Europe on the path toward a pro-innovation, pro-consumer choice, and pro-science future. We at the Consumer Choice Center call on the Commission to reconsider its antiquated approach to beating cancer and recognise the life-saving potential of vaping. Let us make the most out of a once-in-generation opportunity to put in place a policy that saves lives,” concluded Bertoletti.

Consumer advocacy group sends a letter on airport slots waiver to Brussels

Brussels, BE – Today, the Consumer Choice Center, the consumer advocacy group representing and empowering consumers in the EU and globally, sent a letter to Director-General Henrik Hololei to express their deep concerns about the Commission’s intention to extend the waiver of the “use-it-or-lose-it” rule for the entire 2020-2021 winter season.

source http://meltwater.pressify.io/publication/5f52525e9647c10004433e5f/5aa837df2542970e001981f6

Russian Apple law: a cold war with an American tech giant?

Moscow, Russia – Fedot Tumusov, a member of the Russian State Duma, proposed a law that would force Apple to cut app store commission fees down from 30 per cent to 20 per cent. The law would require that a third of the app store commission be paid to the Russian government as part of a fund to train IT specialists.

source http://meltwater.pressify.io/publication/5f4fafd8d1b2be0004703567/5aa837df2542970e001981f6

Airport Ranking: Zurich is Europe’s best airport

“This year has been one of the most challenging for the global travel industry. Many airports were closed for weeks or even months. While travel slowly recovers we want to inform consumers which airports are the most convenient to travel from and to in Europe. Airports with more space per passenger rank higher in our analysis. This is helpful to know for travelers who try to maintain distance from others. If you have to travel this Summer, you might want to consider starting or ending your journey at well-designed airports such as Zurich, Düsseldorf, or Copenhagen.

source http://meltwater.pressify.io/publication/5f4f67bc320adf0004990e62/5aa837df2542970e001981f6

L’inps ha violato la privacy di milioni di Italiani

Nonostante questa scelta dei parlamentari possa essere considerata inopportuna, e sicuramente è l’ennesima prova di una classe politica inadeguata,  l’INPS e il suo presidente questa volta hanno superato ogni limite della legalità. – dice Luca Bertoletti, responsabile Europeo del Consumer Choice Center. 

source http://meltwater.pressify.io/publication/5f316219a7aa51000478ab54/5aa837df2542970e001981f6

Großbritannien ist kein Vorbild beim Kampf gegen Übergewicht — Bevormundung ist der falsche Weg — Deutschland braucht Aufklärung und Innovation

Maria Chaplia, European Affairs Associate für das Consumer Choice Center, meint dass ein Verbot von Fernsehwerbung und die generelle Einführung von Werbebeschränkungen die Fettleibigkeitsrate nicht senke, sondern stattdessen erheblichen wirtschaftlichen Schaden verursachen würde. Außerdem bevormundeten sie die Verbraucher und würden die Meinungsfreiheit untergraben.

source http://meltwater.pressify.io/publication/5f31203815f14a000445fa50/5aa837df2542970e001981f6

Germany shouldn’t follow the UK’s flawed obesity strategy

“Overall, ad bans would target consumption of junk food but it is the exercise that many children lack. According to a report published by the European Commission and the WHO in 2018, only 19% of 11-13-year olds in Germany were physically active. The situation is disastrous, and by opting for junk food ad bans, the German government will simply regulate in the wrong direction.

source http://meltwater.pressify.io/publication/5f2d2bbc59bfc500047e832f/5aa837df2542970e001981f6

Scrapping COVID Patents: PM Johnson needs to resist populist calls

FOR IMMEDIATE RELEASE:

Image

CONTACT:

Fred Roeder, Managing Director, Consumer Choice Center

Scrapping COVID Patents: PM Johnson needs to resist populist calls

London, UK –  In a report published today by the House of Commons International Trade Committee, Members of Parliament suggest to allow for compulsory licensing of drugs for COVID-19. Under compulsory licensing laws, a government has the power to revoke patent rights from innovators or companies if a discovery they made provides vital treatment or protection related to a national health emergency. Fred Roeder, Health Economist and Managing Director of the Consumer Choice Center warns that such erosion of intellectual property would lead to the opposite and eventually harm patients:

“Compulsory licensing is threatening to move the goalposts on how intellectual property rights are protected. If domestic and foreign companies are prevented from retaining their patent licenses, this could hinder the production and supply of essential goods to the population further than they already are. A compulsory licensing bill could place even more barriers for pharmaceutical innovators, which could further discourage these kinds of companies from investing or listing their drugs in the UK.

There are many ways to make easier access to vaccines and drugs for example a mutual recognition of FDA and EMA approvals and fast-tracking some type of medicines. In order to be prepared for the next pandemic, we need to increase and not curb incentives for innovation. Right now we need to do everything that makes pharmaceutical research more agile – Introducing compulsory licensing on COVID drugs and vaccines is not the right way. While might help in the short term but jeopardizes our ability to tackle health crises early on in the long run,” concludes Roeder.

***CCC’ Fred Roeder is available to speak with accredited media on consumer regulations and healthcare issues. Please send media inquiries HERE.***

 

The CCC represents consumers in over 100 countries across the globe. We closely monitor regulatory trends in Ottawa, Washington, Brussels, Geneva and other hotspots of regulation and inform and activate consumers to fight for #ConsumerChoice. Learn more at consumerchoicecenter.org

Scroll to top